Chinoporos Constantine

Chinoporos Constantine is listed in filings as Director at Geron Corporation. This profile follows SEC Form 4 activity through Mar 26, 2026, including sale activity. Recent filings connect the profile to Geron Corporation (GERN) and Applied Therapeutics, Inc. (APLT). The current snapshot covers public activity from Feb 7, 2025 to Mar 26, 2026. Reported amounts are shown as $423.9K to $197. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.